Active	Status	Sponsor type	Region	Phase	Filter
10 Active 6 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nieto, Alicia Rico
NCT05201079: Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin	Completed	3	93	Europe	MBK-01, Fecal microbiota transfer, Dificlir, Fidaxomicin	Mikrobiomik Healthcare Company S.L.	Recurrent Clostridium Difficile Infection, Primary Clostridium Difficile Infection	11/23	11/23
Rodríguez, Ana María
GEM21menos65, NCT05558319: NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide	Not yet recruiting	3	480	Europe	Bortezomib, Isatuximab, Iberdomide, Lenalidomide, Dexamethasone	PETHEMA Foundation, Bristol-Myers Squibb, Sanofi, Adknoma, Start from scratch	Newly Diagnosed Multiple Myeloma	04/27	04/29
Olmos, Miguel A Martínez
PALISADE, NCT05089084 / 2021-003680-10: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)	Active, not recruiting	3	75	Europe, Canada, Japan, US, RoW	Plozasiran, ARO-APOC3, Placebo	Arrowhead Pharmaceuticals	Familial Chylomicronemia	04/24	04/26
DRECO, NCT05433831: Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patients With Nutritional Risk: Study	Recruiting	N/A	1000	Europe		K Access Health Projects, Abbott	Nutrition Disorders, Malnutrition	06/22	12/22
Blanco, Ana Cantón
ARACOV-02, NCT06063031: Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition	Completed	N/A	146	Europe	Active, Placebo	Instituto de Investigación Sanitaria Aragón, Solutex GC S.L.	Post-COVID Condition	09/23	01/24